Population Health Learning Network

Population Health Learning Network

The Population Health Learning Network is an online platform designed for healthcare professionals and leaders. It centers around important topics related to managing the health of populations.

Trade/B2B
English
Research Company/Group

Outlet metrics

Domain Authority
67
Ranking

Global

#219293

United States

#77108

Health/Medicine

#733

Traffic sources
Monthly visitors

Articles

  • 2 weeks ago | hmpgloballearningnetwork.com | Hannah Musick

    A recent real-world analysis comparing chimeric antigen receptor (CAR) T-cell therapy to standard non–CAR T treatments for relapsed/refractory mantle cell lymphoma (R/R MCL) found that patients receiving CAR T therapy experienced fewer follow-up treatments, longer treatment-free intervals, and reduced health care costs. The study included 2835 patients treated with non–CAR T standard of care and 122 patients treated with CAR T therapy, all with at least 2 prior lines of therapy.

  • 1 month ago | hmpgloballearningnetwork.com | Neil Shah

    In this interview, Dr Neil Shah discusses the challenges of treatment sequencing for metastatic renal cell carcinoma (mRCC) after immune checkpoint inhibitor therapy, highlighting findings from his study on post-IO treatment efficacy and the need for novel therapeutic options. Read the full transcript below:Please introduce yourself by stating your name, title, and any relevant clinical experience. Neil Shah, MD: I'm Neil Shah.

  • 1 month ago | hmpgloballearningnetwork.com | Jessica Garlewicz

    A recent study published in RMD Open, evaluating patients with psoriasis (PsO) and subclinical psoriatic arthritis (PsA), highlights the elevated risk of developing PsA in this population. The findings emphasize the importance of monitoring musculoskeletal symptoms in patients with PsO to facilitate early detection and intervention. The study followed 384 patients with PsO for an average of 33 months, with 311 (80.9%) classified as having subclinical PsA.

  • 1 month ago | hmpgloballearningnetwork.com | Eric A. Secemsky

    In this video from CRT 2025, JIC speaks with Dr Eric Secemsky of the Beth Israel Deaconness Medical Center about the future of renal denervation in atrial fibrillation treatment. Transcript:Hi, I'm Eric Secemsky. I'm an interventional cardiologist at the Beth Israel Deaconess Medical Center in Boston, Massachusetts. Can you please briefly explain the physiological link between the renal system and AFib?

  • 1 month ago | hmpgloballearningnetwork.com | Jessica Garlewicz

    News A randomized trial published in Gastroenterology comparing ultrasonography (US) and noncontrast magnetic resonance imaging (MRI) for liver cancer surveillance in cirrhotic patients has found MRI offers significant advantages, including earlier tumor detection and fewer false-positive referrals. These findings could influence surveillance protocols for at-risk patients.